|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00809 GLOBAL BIO-CHEM
Nominal 
0.415 +0.025 (+6.410%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 1,003,814 | -15.360% | 2,278,532 | 2,001,095 | 1,373,938 | 372,278 |
| Cost of Sales | (1,000,899) | -2.331% | (2,082,091) | (1,810,123) | (1,330,301) | (337,681) |
| Gross Profit | 2,915 | -98.192% | 196,441 | 190,972 | 43,637 | 34,597 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (54,829) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | 1,962,112 | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | 5,008,064 | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (206,862) | 33.689% | 156,407 | 745,619 | 3,701,045 | (1,573,784) | |
| Taxation | 0 | -- | (110) | 23,979 | 42,082 | 54,219 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | 481,466 | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 76,497 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (206,862) | 33.689% | 156,297 | 769,598 | 4,224,593 | (1,443,068) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 87,685 | -53.114% | 308,097 | 323,400 | 750,348 | 726,173 |
| Depreciation & Amortisation | 54,465 | 8.804% | 113,643 | 228,506 | 243,563 | 330,509 |
| Directors' Emoluments | -- | -- | 1,511 | 1,600 | 1,246 | 1,429 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Disclaimer |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -12.000 | -33.333% | 14.000 | 86.000 | 474.000 | -162.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.007) | 0.085 | (0.006) | (0.010) |
| NBV per share ($) | (0.485) | -- | (0.309) | (2.202) | (4.532078) | (8.463736) |
| Remarks: | Real time quote last updated: 09/09/2026 13:35 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -206,862 |
| %Change | 33.689% |
| EPS / (LPS) | HKD -0.120 |
| NBV Per Share ($) | HKD -0.485 |